External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

CHARCOT 2026

-
Coming soon
11:30 AM
Duration 60mins Baveno, Italy
Cross-Sectional Associations Between Digital Functional Measures and Patient-Reported Outcome Measures in Multiple Sclerosis
Licinio Craveiro, Roger Mills, Dimitar Stanev, Daniel Leibovitz, Pawel Biernacki, Agne Kazlauskaite, Mike D. Rinderknecht, Carolyn A. Young

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 60mins Baveno, Italy
HLA Association Observed With Liver Enzyme Elevation Risk in Fenebrutinib-Treated Patients With Multiple Sclerosis
Jiwon Oh, Amit Bar-Or, Jennifer S. Graves, Ann E. Herman, Matthew Durk, Julie Napieralski, Esther Nie, Maria Pia Sormani, Miriam Triyatni, Paul B. Watkins, Marina Ziehn, Katrin Madjar and Tushar Bhangale

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 60mins Baveno, Italy
Longitudinal analysis of clinical characteristics and decision drivers of untreated people with Multiple Sclerosis in the German NeuroTransData (NTD) real world registry (2018-2024)
Martin Traber, Stefan Braune, Yanic Heer, Carmen G. Berardo, Ana Ferro, Arnfin Bergmann, Juan Acosta, Mel Zuercher, NTD Study Group

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar